Cognitive Change Clinical Trial
Official title:
The Effects of Exercise on Cognition and Brain Health in Older Adults at Risk for Type 2 Diabetes
Verified date | December 2023 |
Source | Western University, Canada |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Older adults with type 2 diabetes experience neurocognitive decline and are at higher risk for developing dementia. Consequently, older adults at-risk for developing type 2 diabetes (i.e., those who are overweight and/or prediabetic) are at higher risk for neurocognitive decline, and intervening at this point may prevent or delay the onset of such decline. One promising lifestyle intervention that has been shown to improve cognitive function and brain health in other populations is resistance exercise. We previously conducted a 6-month resistance training randomized controlled trial (RCT) pilot study that showed a large scale trial would be viable and feasible. Consequently, we would like to explore resistance exercise as a lifestyle intervention to improve cognition and brain structure in older adults at risk for diabetes.
Status | Active, not recruiting |
Enrollment | 60 |
Est. completion date | June 30, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. Community-dwelling 2. Aged 60-80 years 3. "At-risk" for diabetes, where they have one of the following: i) blood glucose level of 6.1-7 mmol/L, ii) body mass index > 25, or iii) score > 21 on the CANRISK diabetes questionnaire 4. Score > 24/30 on MMSE 5. Score > 6/8 on the IADL scale 6. Visual acuity of at least 20/40, with or without corrective lenses 7. Speak and understand English fluently 8. Complete the PAR-Q 9. Obtain physician's clearance to start a supervised exercise program Exclusion Criteria: 1. Current medical condition for which exercise is contraindicated 2. Participated regularly in resistance or aerobic training in the last 6 months 3. Diagnosed with neurodegenerative disease (including dementia, Alzheimer's disease, or Parkinson's disease) 4. Experienced a vascular incident (e.g., stroke, myocardial infarction) 5. Diagnosed with a psychiatric condition 6. Untreated depression and scored 5 or less on the Geriatric Depression Scale 7. Currently on hormone replacement therapy 8. Clinically significant peripheral neuropathy or severe musculoskeletal or joint disease 9. Currently taking psychotropic medications 10. Cannot blood draw |
Country | Name | City | State |
---|---|---|---|
Canada | Western University | London | Ontario |
Lead Sponsor | Collaborator |
---|---|
Western University, Canada |
Canada,
Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol. 2004 Nov;26(8):1044-80. doi: 10.1080/13803390490514875. — View Citation
Furlano JA, Nagamatsu LS. Feasibility of a 26-Week Exercise Program to Improve Brain Health in Older Adults at Risk for Type 2 Diabetes: A Pilot Study. Can J Diabetes. 2021 Aug;45(6):546-552. doi: 10.1016/j.jcjd.2020.11.001. Epub 2020 Nov 13. — View Citation
Liu-Ambrose T, Nagamatsu LS, Graf P, Beattie BL, Ashe MC, Handy TC. Resistance training and executive functions: a 12-month randomized controlled trial. Arch Intern Med. 2010 Jan 25;170(2):170-8. doi: 10.1001/archinternmed.2009.494. — View Citation
Nagamatsu LS, Handy TC, Hsu CL, Voss M, Liu-Ambrose T. Resistance training promotes cognitive and functional brain plasticity in seniors with probable mild cognitive impairment. Arch Intern Med. 2012 Apr 23;172(8):666-8. doi: 10.1001/archinternmed.2012.379. No abstract available. Erratum In: Arch Intern Med. 2013 Aug 12;173(15):1477. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Trail Making Test | Used to assess executive function in the areas of visual attention (Part A) and set-shifting (the ability to shift attention between one task and another; Part B). The time to complete this test is recorded in seconds. | 5 minutes | |
Secondary | Paired Associative Learning (PAL) Touchscreen Task | Used to test learning and remembering of three objects that are associated with a correct spatial location on the screen. | 20 minutes | |
Secondary | Trail Unique-Non-Matching-Location (TUNL) Task | This is a working spatial memory task that involves selecting a different stimulus (non-matching) to the stimulus presented on the screen after a delay period. The stimuli are presented in locations far apart or close together to challenge spatial memory. | 20 minutes | |
Secondary | Progressive Ratio (PR) Touchscreen Task | This task tests motivation and attention. The task involves touching a square stimulus at the center of the screen repeatedly for points in a single trial. The number of touches required for points increases on a ramp scale, which begins at one touch for points and then is increased by four on each subsequent trial for points. If the participant stops responding for 5 minutes, the task stops, and the point of break (stopping) is recorded. | 20 minutes | |
Secondary | Stroop Test | Used to assess executive function in the areas of selective attention, processing speed, and cognitive flexibility. The time to complete this test is recorded in seconds. | 5-10 minutes | |
Secondary | Digit Span Test | Used to assess working memory. Participants are required to memorize and recall a series of number lists both forward and backward. | 5-10 minutes | |
Secondary | Alzheimer's Disease Assessment Scale Cognitive Subscale 11 | Test with 11 tasks measuring various cognitive functions (memory, language, praxis, attention). Used widely in clinical trials to assess cognitive dysfunction and Alzheimer's Disease. | 15 minutes | |
Secondary | Glycated hemoglobin A1c (HbA1C) | We will collect blood samples to test glycated hemoglobin levels to determine diabetes status (pre-diabetes, diabetes). Blood will be drawn from a cubital vein into a 7.5 ml tube. Blood draws will be done by RN Arlene Fleischhauer in Co-I Kevin Shoemaker's lab or by trained support staff, Olivia Ghosh-Swaby. | 5-10 minutes | |
Secondary | Fasting plasma glucose | We will collected via a glucometer finger prick | 5-10 minutes | |
Secondary | Height | Measured in m; used to calculate body mass index (kg/m^2) | 5 minutes | |
Secondary | Weight | Measured in kg; used to calculate body mass index (kg/m^2) | 5 minutes | |
Secondary | Triglyceride levels | Will be assessed via serum samples measured by ELISA. | 30 minutes | |
Secondary | Inflammatory markers | Will be assessed via serum samples measured by ELISA. | 30 minutes | |
Secondary | Brain-derived neurotrophic factor levels | Will be assessed via serum samples measured by ELISA. | 1 hour | |
Secondary | Insulin-like growth factor levels | Will be assessed via serum samples measured by ELISA. | 1 hour | |
Secondary | One repetition maximum | One-repetition maximum is a physical measure of an individual's maximum muscle strength during a single repetition and is used to determine the desired load for resistance training. | 10-15 minutes | |
Secondary | Six-minute walk test | Used to assess aerobic fitness. Participants walk at their usual speed for a total of 6 minutes in the hallway outside of our lab. The total distance walked in meters is recorded. | 6 minutes | |
Secondary | Short Physical Performance Battery (SPPB) - Task 1 | Used to assess gait speed, balance, and lower extremity physical function using tasks that mimic daily activities; the Standing Balance Task requires participants to stand unassisted (side-by-side standing, semi-tandem standing, and tandem standing) for a period of 10 seconds each; scored in conjunction with SPPB Tasks 2 & 3 to produce one final SPPB score | 5 minutes | |
Secondary | Short Physical Performance Battery (SPPB) - Task 2 | Used to assess gait speed, balance, and lower extremity physical function using tasks that mimic daily activities; the Walking Speed Task requires participants to walk 4 metres at their usual pace; measured in seconds; scored in conjunction with SPPB Tasks 1 & 3 to produce one final SPPB score | 5 minutes | |
Secondary | Short Physical Performance Battery (SPPB) - Task 3 | Used to assess gait speed, balance, and lower extremity physical function using tasks that mimic daily activities; the Chair Stand Test requires participants to stand up from a chair 5 times consecutively (without the use of their arms if possible); measured in seconds; scored in conjunction with SPPB Tasks 1 & 2 to produce one final SPPB score | 5 minutes | |
Secondary | Timed Up and Go Test | Used to assess mobility. Participants are seated in a chair and must stand up, walk a distance of 3 meters at their usual pace, turn around, return to their chair, and sit back down. The time to complete each of two separate trials is recorded in seconds. | 5-10 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05712005 -
Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding of Cognivue Study
|
||
Completed |
NCT05343208 -
Effectiveness of Online Therapy to Prevent Burnout
|
N/A | |
Active, not recruiting |
NCT05143294 -
Conectar Jugando: Board Games in Elementary Classrooms (6-12 Years Old) to Improve Executive Functions
|
N/A | |
Completed |
NCT05267730 -
Conectar Jugando: Board Games in Rural Elementary Classrooms (6-12 Years Old) to Improve Executive Functions
|
N/A | |
Completed |
NCT03987477 -
Online Intervention to Modify Interpretation Biases in Depression
|
N/A | |
Completed |
NCT03695003 -
Cognitive Effects of Sage in Healthy Humans
|
N/A | |
Completed |
NCT05075850 -
Multicenter Sub-study for LAANTERN Registry NCT02392078 That Will Include Comprehensive Neuropsychological Assessment Data Collection
|
||
Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
Completed |
NCT03674281 -
The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System
|
N/A | |
Completed |
NCT03689348 -
Acute and Chronic Effects of Avena Sativa on Cognition and Stress
|
N/A | |
Suspended |
NCT05001789 -
Cognitive Functioning in Opioid Use Disorder
|
N/A | |
Terminated |
NCT03337282 -
Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
|
||
Recruiting |
NCT05014399 -
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
|
||
Completed |
NCT03657537 -
Effects of Ketone Bodies on Cognition in Type 2 Diabetes
|
Phase 1 | |
Completed |
NCT05543811 -
The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology
|
N/A | |
Recruiting |
NCT05699226 -
Amplitude Titration to Improve ECT Clinical Outcomes
|
N/A | |
Recruiting |
NCT05026541 -
Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators
|
N/A | |
Active, not recruiting |
NCT03255499 -
Efficacy of the MovinCog Intervention in Children
|
N/A | |
Not yet recruiting |
NCT06252376 -
Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD
|
N/A | |
Recruiting |
NCT06099405 -
Yoga Training and Retinal Vasculature
|
N/A |